Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


10.04.2017

1 Acta Haematol
3 Am J Clin Pathol
7 Am J Hematol
3 Ann Oncol
1 BMJ
2 Bone Marrow Transplant
2 Cancer
1 Clin Infect Dis
1 Eur J Haematol
2 Int J Hematol
2 J Clin Oncol
1 J Natl Cancer Inst
1 J Virol
4 Leuk Lymphoma
2 Leuk Res
2 Leukemia
1 Oncogene
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Haematol

  1. PTACKOVA P, Petrackova M, Hindos M, Duskova M, et al
    Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients.
    Acta Haematol. 2017;137:148-157.
    PubMed     Text format     Abstract available


    Am J Clin Pathol

  2. ROGERS HJ, Hsi ED, Tang G, Wang SA, et al
    Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study.
    Am J Clin Pathol. 2017;147:411-419.
    PubMed     Text format     Abstract available

  3. MORRISON AO, Morris R, Shannon A, Lauer SR, et al
    Disseminated Acanthamoeba Infection Presenting With Cutaneous Lesions in an Immunocompromised Patient: A Case Report, Review of Histomorphologic Findings, and Potential Diagnostic Pitfalls.
    Am J Clin Pathol. 2016;145:266-70.
    PubMed     Text format     Abstract available

  4. OK CY, Leventaki V, Wang SA, Dinardo C, et al
    Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy.
    Am J Clin Pathol. 2016;145:271-6.
    PubMed     Text format     Abstract available


    Am J Hematol

  5. ALFONSO A, Montalban-Bravo G, Takahashi K, Jabbour EJ, et al
    Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.
    Am J Hematol. 2017 Mar 28. doi: 10.1002/ajh.24735.
    PubMed     Text format     Abstract available

  6. KANTARJIAN HM, Schuster MW, Jain N, Advani A, et al
    A Phase 1 Study of AMG 900, an Orally Administered Pan-Aurora Kinase Inhibitor, in Adult Patients With Acute Myeloid Leukemia.
    Am J Hematol. 2017 Mar 28. doi: 10.1002/ajh.24736.
    PubMed     Text format     Abstract available

  7. CANAANI J, Labopin M, Socie G, Nihtinen A, et al
    Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: an analysis from the acute leukemia working party of the EBMT.
    Am J Hematol. 2017 Mar 28. doi: 10.1002/ajh.24737.
    PubMed     Text format     Abstract available

  8. WEINBERG OK, Gibson CJ, Blonquist TM, Neuberg D, et al
    NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO Classification.
    Am J Hematol. 2017 Mar 28. doi: 10.1002/ajh.24739.
    PubMed     Text format    

  9. SACHA T, Gora-Tybor J, Szarejko M, Bober G, et al
    A multicenter prospective study on efficacy and safety of imatinib generics; a report from Polish Adult Leukemia Group imatinib generics registry.
    Am J Hematol. 2017 Apr 4. doi: 10.1002/ajh.24748.
    PubMed     Text format     Abstract available

  10. REDA G, Cassin R, Fattizzo B, Giannarelli D, et al
    Chronic lymphocytic leukemia (CLL) and prognostic models: A bridge between clinical and biological markers.
    Am J Hematol. 2017 Apr 6. doi: 10.1002/ajh.24755.
    PubMed     Text format    

  11. BAPTISTA MJ, Granada I, Morgades M, Calasanz MJ, et al
    Monosomal karyotype in chronic lymphocytic leukemia: association with clinical and biological features and potential prognostic significance.
    Am J Hematol. 2017 Apr 6. doi: 10.1002/ajh.24754.
    PubMed     Text format    


    Ann Oncol

  12. VOSO MT, Leone G, Piciocchi A, Fianchi L, et al
    in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study.
    Ann Oncol. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. FRIBERG G, Reese D
    Blinatumomab (Blincyto(R)); lessons learned from the bispecific t-cell engager (BiTE(R)) in acute lymphocytic leukemia (ALL).
    Ann Oncol. 2017 Mar 31. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. JAIN P, Aoki E, Keating M, Wierda WG, et al
    Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).
    Ann Oncol. 2017 Apr 4. doi: 10.1093.
    PubMed     Text format     Abstract available


    BMJ

  15. HEY SP, Kesselheim AS
    The FDA, Juno Therapeutics, and the ethical imperative of transparency.
    BMJ. 2016;354:i4435.
    PubMed     Text format    


    Bone Marrow Transplant

  16. SELLNER L, Bruggemann M, Schlitt M, Knecht H, et al
    GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses.
    Bone Marrow Transplant. 2017;52:656.
    PubMed     Text format    

  17. YAMASAKI S, Suzuki R, Hatano K, Fukushima K, et al
    Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma.
    Bone Marrow Transplant. 2017 Apr 3. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


    Cancer

  18. BODDU PC, Kantarjian HM, Ravandi F, Garcia-Manero G, et al
    Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach.
    Cancer. 2017 Apr 7. doi: 10.1002/cncr.30704.
    PubMed     Text format     Abstract available

  19. BATTIPAGLIA G, Ruggeri A, Massoud R, El Cheikh J, et al
    Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia.
    Cancer. 2017 Apr 7. doi: 10.1002/cncr.30680.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  20. WEBB BJ, Healy R, Majers J, Burr Z, et al
    Prediction of Bloodstream Infection due to Vancomycin-Resistant Enterococci in Patients Undergoing Leukemia Induction or Hematopoietic Stem Cell Transplantation.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur J Haematol

  21. ZADA M, Lerner D, Piltz Y, Perry C, et al
    Familial Chronic Lymphocytic Leukemia in Israel: A Disproportionate Distribution Among Ashkenazi Jews.
    Eur J Haematol. 2017 Mar 31. doi: 10.1111/ejh.12889.
    PubMed     Text format     Abstract available


    Int J Hematol

  22. SUH KJ, Lee JY, Shin DY, Koh Y, et al
    Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials.
    Int J Hematol. 2017 Apr 4. doi: 10.1007/s12185-017-2225.
    PubMed     Text format     Abstract available

  23. YAGUCHI A, Ishibashi T, Terada K, Ueno-Yokohata H, et al
    EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells.
    Int J Hematol. 2017 Apr 4. doi: 10.1007/s12185-017-2220.
    PubMed     Text format     Abstract available


    J Clin Oncol

  24. BRADSTOCK KF, Link E, Di Iulio J, Szer J, et al
    Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
    J Clin Oncol. 2017 Apr 3:JCO2016706374. doi: 10.1200/JCO.2016.70.6374.
    PubMed     Text format     Abstract available

  25. SCOTT BL, Pasquini MC, Logan BR, Wu J, et al
    Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    J Clin Oncol. 2017;35:1154-1161.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  26. MOZESSOHN L, Earle C, Spaner D, Cheng SY, et al
    The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study.
    J Natl Cancer Inst. 2017;109:1-9.
    PubMed     Text format     Abstract available


    J Virol

  27. LIBERATORE RA, Mastrocola EJ, Powell C, Bieniasz PD, et al
    Tetherin Inhibits Cell-free Virus Dissemination and Retards Murine Leukemia Virus Pathogenesis.
    J Virol. 2017 Apr 5. pii: JVI.02286-16. doi: 10.1128/JVI.02286.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  28. ROBESOVA B, Jeziskova I, Krejci M, Mayer J, et al
    Genesis of new allele at locus D2S1360 in leukemia patient.
    Leuk Lymphoma. 2017 Apr 3:1-4. doi: 10.1080/10428194.2017.1307363.
    PubMed     Text format    

  29. HARIVENKATESH N, Kumar L, Bakhshi S, Sharma A, et al
    Do polymorphisms in MDR1 and CYP3A5 genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinib therapy?
    Leuk Lymphoma. 2017 Apr 3:1-9. doi: 10.1080/10428194.2017.1287359.
    PubMed     Text format     Abstract available

  30. WASHIO K, Oka T, Abdalkader L, Muraoka M, et al
    Gene expression analysis of hypersensitivity to mosquito bite, chronic active EBV infection and NK/T-lymphoma/leukemia.
    Leuk Lymphoma. 2017 Apr 3:1-12. doi: 10.1080/10428194.2017.1304762.
    PubMed     Text format     Abstract available

  31. BOSCH R, Mora A, Vicente EP, Ferrer G, et al
    FcgammaRIIb expression in early stage chronic lymphocytic leukemia.
    Leuk Lymphoma. 2017 Apr 4:1-7. doi: 10.1080/10428194.2017.1307981.
    PubMed     Text format     Abstract available


    Leuk Res

  32. LI Y, Liu X, Guo X, Liu X, et al
    DNA methyltransferase 1 mediated aberrant methylation and silencing of SHP-1 gene in chronic myelogenous leukemia cells.
    Leuk Res. 2017;58:9-13.
    PubMed     Text format     Abstract available

  33. BILOUS N, Abramenko I, Saenko V, Chumak A, et al
    Clinical relevance of TP53 polymorphic genetic variations in chronic lymphocytic leukemia.
    Leuk Res. 2017;58:1-8.
    PubMed     Text format     Abstract available


    Leukemia

  34. JONES D, Woyach JA, Zhao W, Caruthers S, et al
    PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment.
    Leukemia. 2017 Apr 3. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  35. SILVA P, Neumann M, Schroeder MP, Vosberg S, et al
    Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscape.
    Leukemia. 2017 Apr 3. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    Oncogene

  36. MADAPURA HS, Nagy N, Ujvari D, Kallas T, et al
    Interferon gamma is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    PLoS One

  37. JABO B, Morgan JW, Martinez ME, Ghamsary M, et al
    Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients.
    PLoS One. 2017;12:e0174760.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: